Yarmishyn and colleagues have speculated that this is a compensatory response, with HOXD-AS1 promoting the differentiation of metastatic neuroblastoma cell populations characterized by an overall loss of differentiation capacity [85]. The gene discussed is HAGLR; the disease is neuroblastoma.